Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Steven J M, Jones"'
Autor:
Irene S, Yu, Kathleen, Wee, Laura, Williamson, Emma, Titmuss, Jianghong, An, Sheida, Naderi-Azad, Corey, Metcalf, Stephen, Yip, Basil, Horst, Steven J M, Jones, Katherine, Paton, Brad H, Nelson, Marco, Marra, Janessa J, Laskin, Kerry J, Savage
Publikováno v:
Melanoma Research. 32:278-285
Uveal melanoma is the most common intraocular malignancy and has a poor prognosis compared to other melanoma subtypes with a median overall survival of 6-10 months. With immune checkpoint inhibitor therapy, either PD-1 inhibitor alone or combination
Autor:
Erica S. Tsang, Veronika Csizmok, Laura M. Williamson, Erin Pleasance, James T. Topham, Joanna M. Karasinska, Emma Titmuss, Intan Schrader, Stephen Yip, Basile Tessier-Cloutier, Karen Mungall, Tony Ng, Sophie Sun, Howard J. Lim, Jonathan M. Loree, Janessa Laskin, Marco A. Marra, Steven J. M. Jones, David F. Schaeffer, Daniel J. Renouf
Publikováno v:
npj Precision Oncology. 7
There is emerging evidence about the predictive role of homologous recombination deficiency (HRD), but this is less defined in gastrointestinal (GI) and thoracic malignancies. We reviewed whole genome (WGS) and transcriptomic (RNA-Seq) data from adva
Autor:
Elie J. Ritch, Cameron Herberts, Evan W. Warner, Sarah W. S. Ng, Edmond M. Kwan, Jack V. W. Bacon, Cecily Q. Bernales, Elena Schönlau, Nicolette M. Fonseca, Veda N. Giri, Corinne Maurice-Dror, Gillian Vandekerkhove, Steven J. M. Jones, Kim N. Chi, Alexander W. Wyatt
Publikováno v:
npj Precision Oncology. 7
Specific classes of DNA damage repair (DDR) defect can drive sensitivity to emerging therapies for metastatic prostate cancer. However, biomarker approaches based on DDR gene sequencing do not accurately predict DDR deficiency or treatment benefit. S
Autor:
Zhiping Li, Xuanmao Jiao, A. Gordon Robertson, Gabriele Di Sante, Anthony W. Ashton, Agnese DiRocco, Min Wang, Jun Zhao, Sankar Addya, Chenguang Wang, Peter A. McCue, Andrew P. South, Carlos Cordon-Cardo, Runzhi Liu, Kishan Patel, Rasha Hamid, Jorim Parmar, James B. DuHadaway, Steven J. M. Jones, Mathew C. Casimiro, Nikolaus Schultz, Andrew Kossenkov, Lai Yee Phoon, Hao Chen, Li Lan, Yunguang Sun, Kenneth A. Iczkowski, Hallgeir Rui, Richard G. Pestell
Prostate cancer (PCa), the second leading cause of death in American men, includes distinct genetic subtypes with distinct therapeutic vulnerabilities. The DACH1 gene encodes a winged helix/Forkhead DNA-binding protein that competes for binding to FO
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7616db62792d155d6ed1a1bb5414cfdd
https://doi.org/10.21203/rs.3.rs-2423179/v1
https://doi.org/10.21203/rs.3.rs-2423179/v1
Autor:
Laura M. Williamson, Craig M. Rive, Daniela Di Francesco, Emma Titmuss, Hye-Jung E. Chun, Scott D. Brown, Katy Milne, Erin Pleasance, Anna F. Lee, Stephen Yip, Daniel G. Rosenbaum, Martin Hasselblatt, Pascal D. Johann, Marcel Kool, Melissa Harvey, David Dix, Daniel J. Renouf, Robert A. Holt, Brad H. Nelson, Martin Hirst, Steven J. M. Jones, Janessa Laskin, Shahrad R. Rassekh, Rebecca J. Deyell, Marco A. Marra
Publikováno v:
npj Precision Oncology, Vol 5, Iss 1, Pp 1-12 (2021)
NPJ Precision Oncology
NPJ Precision Oncology
Poorly differentiated chordoma (PDC) is a recently recognized subtype of chordoma characterized by expression of the embryonic transcription factor, brachyury, and loss of INI1. PDC primarily affects children and is associated with a poor prognosis a
Autor:
Kilannin Krysiak, Arpad M. Danos, Susanna Kiwala, Joshua F. McMichael, Adam C. Coffman, Erica K. Barnell, Lana Sheta, Jason Saliba, Cameron J. Grisdale, Lynzey Kujan, Shahil Pema, Jake Lever, Nicholas C. Spies, Andreea Chiorean, Damian T. Rieke, Kaitlin A. Clark, Payal Jani, Hideaki Takahashi, Peter Horak, Deborah I. Ritter, Xin Zhou, Benjamin J. Ainscough, Sean Delong, Mario Lamping, Alex R. Marr, Brian V. Li, Wan-Hsin Lin, Panieh Terraf, Yasser Salama, Katie M. Campbell, Kirsten M. Farncombe, Jianling Ji, Xiaonan Zhao, Xinjie Xu, Rashmi Kanagal-Shamanna, Kelsy C. Cotto, Zachary L. Skidmore, Jason R. Walker, Jinghui Zhang, Aleksandar Milosavljevic, Ronak Y. Patel, Rachel H. Giles, Raymond H. Kim, Lynn M. Schriml, Elaine R. Mardis, Steven J. M. Jones, Gordana Raca, Shruti Rao, Subha Madhavan, Alex H. Wagner, Obi L. Griffith, Malachi Griffith
Publikováno v:
Nat Cancer
As guidelines, therapies, and literature on cancer variants expand, the lack of consensus variant interpretations impedes clinical applications. CIViC is a public domain, crowd-sourced, and adaptable knowledgebase of evidence for the Clinical Interpr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ed50e6a9356f3f2f4e3e63d326c2871
https://eprints.gla.ac.uk/279775/1/279775.pdf
https://eprints.gla.ac.uk/279775/1/279775.pdf
Autor:
Ana Nikolic, Anna Bobyn, Francesca Maule, Katrina Ellestad, Seungil Paik, Sajid Marhon, Parinaz Mehdipour, Xuequng Lun, Michael Johnston, Christopher Gafiuk, Franz Zemp, Yaoqing Shen, Nicoletta Ninkovic, Elodie Labit, N Daniel Berger, Duncan Brownsey, John Kelly, Jeff Biernaskie, Peter Dirks, Darren Derksen, Steven J M Jones, Donna L Senger, Jennifer Chan, Douglas J Mahoney, Daniel de Carvalho, Marco Gallo
Publikováno v:
Neuro-Oncology. 24:vii34-vii34
Glioblastoma is a highly malignant tumour driven by a subset of self-renewing cells termed glioblastoma stem cells. This self-renewal phenotype is largely epigenetically driven, however, the exact epigenetic mechanisms underpinning it are poorly unde
Autor:
Dean A Regier, Deirdre Weymann, Brandon Chan, Cheryl Ho, Howard John Lim, Stephen Yip, Rebekah Rittberg, Sophie Sun, Marco A. Marra, Steven J. M. Jones, Janessa J. Laskin, Samantha Pollard
Publikováno v:
Journal of Clinical Oncology. 40:e18704-e18704
e18704 Background: Rapid advances in precision oncology challenge timely and sustainable reimbursement decisions. Life-cycle health technology assessment (LC-HTA) can enable conditional patient access to promising precision oncology innovations along
Autor:
Erica S Tsang, James T. Topham, Joanna Karasinska, Steve Kalloger, Veronika Csizmok, Laura Williamson, Hui-Li Wong, Grainne M. O'Kane, Jonathan M. Loree, Faiyaz Notta, Oliver F. Bathe, Patricia A. Tang, Rachel Anne Goodwin, Jennifer J. Knox, Steven Gallinger, Janessa J. Laskin, Marco A. Marra, Steven J. M. Jones, David F. Schaeffer, Daniel John Renouf
Publikováno v:
Journal of Clinical Oncology. 40:587-587
587 Background: Oncogenic driver mutations in KRAS represent a hallmark genomic event in approximately 90% of pancreatic adenocarcinoma (PDAC). For the remaining 10% of patients with KRAS wildtype (wt) PDAC, distinct driver mutations have been descri
Autor:
Gregory A. Taylor, Emma Tittmus, D.J. Renouf, Kathleen Wee, Karen Mungall, Richard A. Moore, Yaoqing Shen, Lim Howard John, Veronika Csizmok, Alexandra Bohm, Caralyn Reisle, Steven J. M. Jones, Erin Pleasance, Janessa Laskin, Melika Bonakdar, Jessica Nelson, Marco Marra, Sophie Sun, Andrew J. Mungall, Eric Chuah, Balvir Deol, Laura Williamson, Martin Jones
Publikováno v:
Cancer Research. 81:98-98
Sequencing technology is increasingly essential in clinical cancer management. The majority of clinical cancer sequencing has focused on panel approaches, but recent trials have begun to report the use of transcriptome expression profiling to match p